This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Morgan Stanley Senior Funding, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Rob De Jong: Innovator in Antibody Variants
Introduction
Rob De Jong is a notable inventor based in Utrecht, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of antibody variants. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Rob De Jong holds a patent for "ANTIBODY VARIANT COMBINATIONS AND USES THEREOF." This patent highlights his research and development efforts in creating effective antibody combinations that can be utilized in various therapeutic applications. His work in this area is crucial for the ongoing advancements in targeted therapies.
Career Highlights
Rob is currently employed at Morgan Stanley Senior Funding, Inc., where he applies his scientific knowledge in a corporate setting. His role allows him to bridge the gap between innovative research and practical applications in the financial aspects of biotechnology.
Collaborations
Throughout his career, Rob has collaborated with talented individuals such as Frank Beurskens and Gijs Zom. These partnerships have fostered a creative environment that encourages the exchange of ideas and enhances the development of innovative solutions.
Conclusion
Rob De Jong is a distinguished inventor whose work in antibody variants is paving the way for future advancements in biotechnology. His contributions are vital to the ongoing evolution of medical treatments and therapies.